This article, written by Dr Amrita Singh, is valued at one hour CMA CPD. Instructions to upload this to your log are at the end of the article. To find more CMA/CPD opportunities, please visit the CMA/CPD page here.

Addison’s disease, also known as primary adrenal insufficiency, is a rare long-term endocrine disorder in which the adrenal glands do not produce enough essential hormones—primarily cortisol and aldosterone (NHS, 2021). These hormones are vital for regulating metabolism, blood pressure, immune responses, salt–water balance, and the body’s ability to cope with physical and emotional stress (Mayo Clinic, 2024).

The condition most commonly develops when the immune system mistakenly attacks and damages the adrenal cortex, leading to reduced hormone production (Cleveland Clinic, 2022). Less commonly, Addison’s disease may result from infections such as tuberculosis, adrenal haemorrhage, genetic conditions, or as a consequence of certain medications or cancers affecting the adrenal glands (NHS, 2021; Mayo Clinic, 2024).

Because cortisol and aldosterone influence multiple body systems, Addison’s disease often presents with non-specific and slowly progressing symptoms, such as persistent fatigue, unintentional weight loss, low blood pressure, dizziness, muscle weakness, salt craving, and skin hyperpigmentation (NHS, 2021). If left undiagnosed or untreated, it can lead to a life-threatening complication known as an adrenal crisis, which requires urgent medical attention (Cleveland Clinic, 2022).

Although Addison’s disease cannot be cured, it can be effectively managed with lifelong hormone replacement therapy and appropriate medical monitoring, allowing most individuals to lead active and stable lives (National Institute of diabetes and Digestive and Kidney Diseases, 2019).

Types

Addison’s disease itself refers specifically to primary adrenal insufficiency, but adrenal insufficiency is broadly classified into three main types based on the underlying cause and where hormone disruption occurs (NHS, 2021; Mayo Clinic, 2024).

Primary adrenal insufficiency (Addison’s disease) occurs when the adrenal glands are directly damaged and are unable to produce sufficient cortisol and aldosterone. This damage is most commonly caused by autoimmune destruction of the adrenal cortex but may also result from infections (such as tuberculosis), adrenal haemorrhage, cancer, or surgical removal of the adrenal glands (NHS, 2021; Cleveland Clinic, 2022).

Secondary adrenal insufficiency develops when the pituitary gland does not produce enough adrenocorticotropic hormone (ACTH), which normally stimulates the adrenal glands to release cortisol. In this form, the adrenal glands themselves are structurally intact, and aldosterone production is usually preserved. Secondary adrenal insufficiency most often occurs after sudden withdrawal of long-term corticosteroid therapy, which suppresses normal ACTH production (Mayo Clinic, 2024; National Institute of diabetes and Digestive and Kidney Diseases, 2019).

Tertiary adrenal insufficiency is related to dysfunction at the level of the hypothalamus, which fails to release sufficient corticotropin-releasing hormone (CRH). This also results in reduced ACTH and cortisol production and is commonly associated with prolonged use of external steroid medication or disorders affecting hypothalamic regulation (Cleveland Clinic, 2022).

While all three types share overlapping symptoms related to cortisol deficiency, Addison’s disease is distinct in that it involves both cortisol and aldosterone deficiency, making it more likely to cause electrolyte imbalance, low blood pressure, and hyperpigmentation compared with secondary or tertiary forms (NHS, 2021; Mayo Clinic, 2024).

Causes

Addison’s disease occurs when the adrenal cortex is damaged, leading to inadequate production of cortisol and aldosterone (NHS, 2021). The causes can be grouped into autoimmune, infectious, iatrogenic, and other less common medical causes.

Autoimmune destruction is the most common cause in the UK and other developed countries. In this condition, the immune system mistakenly attacks the adrenal glands, gradually impairing hormone production (NHS, 2021; Mayo Clinic, 2024). Autoimmune Addison’s disease may occur alone or as part of autoimmune polyendocrine syndromes, where multiple endocrine glands are affected (Cleveland Clinic, 2022).

Infections affecting the adrenal glands are another recognised cause. Historically, tuberculosis was a leading cause worldwide and remains relevant in some regions. Other infections, including fungal infections and HIV-related complications, can also damage adrenal tissue (Mayo Clinic, 2024).

Adrenal haemorrhage or infarction, which may occur due to severe infections, blood clotting disorders, trauma, or anticoagulant therapy, can lead to sudden adrenal failure (Cleveland Clinic, 2022). Similarly, cancers that spread to the adrenal glands may disrupt hormone production, although this is less common (NHS, 2021).

Medications and medical treatments can also contribute. Long-term use of corticosteroids followed by abrupt withdrawal may suppress adrenal function, and certain drugs that interfere with steroid synthesis can impair cortisol production (National Institute of diabetes and Digestive and Kidney Diseases, 2019). Surgical removal of the adrenal glands, though rare, will also result in permanent adrenal insufficiency (Mayo Clinic, 2024).

In many cases, adrenal damage progresses slowly, meaning symptoms may not become apparent until a significant proportion of adrenal function has already been lost (NHS, 2021).

Symptoms

The symptoms of Addison’s disease usually develop gradually and insidiously, making early diagnosis challenging. Because cortisol and aldosterone influence multiple physiological systems, the condition often presents with non-specific symptoms that may initially be mistaken for stress, depression, or other chronic illnesses (NHS, 2021; Mayo Clinic, 2024).

One of the most commonly reported symptoms is persistent fatigue, which does not improve with rest and may progressively worsen over time. Individuals may also experience muscle weakness, unintentional weight loss, and reduced appetite, reflecting impaired metabolic regulation due to low cortisol levels (NHS, 2021).

Low blood pressure (hypotension) is another key feature, often leading to dizziness or light-headedness, particularly when standing up (postural hypotension). This occurs due to aldosterone deficiency, which disrupts sodium and fluid balance in the body (Cleveland Clinic, 2022).

A distinctive symptom of Addison’s disease is skin hyperpigmentation, where areas of skin—especially scars, skin creases, gums, and knuckles—become darker. This results from increased production of adrenocorticotropic hormone (ACTH), which stimulates melanocyte activity when cortisol levels are low (Mayo Clinic, 2024).

Other commonly reported symptoms include salt cravings, nausea, vomiting, abdominal pain, and diarrhoea, reflecting electrolyte imbalance and gastrointestinal involvement (NHS, 2021). Some individuals may also experience low mood, irritability, anxiety, or difficulty concentrating, highlighting the role of cortisol in psychological and cognitive functioning (Cleveland Clinic, 2022).

In some cases, Addison’s disease may first present abruptly as an adrenal crisis, a medical emergency characterised by severe weakness, confusion, dehydration, very low blood pressure, and loss of consciousness. This situation requires immediate hospital treatment and can be life-threatening if not promptly managed (National Institute of diabetes and Digestive and Kidney Diseases, 2019).

Risk factors

Addison’s disease is a rare condition, but certain factors can increase an individual’s likelihood of developing primary adrenal insufficiency. These risk factors are primarily linked to immune, genetic, infectious, and medical influences (NHS, 2021).

One of the strongest risk factors is the presence of an autoimmune condition. Individuals with autoimmune disorders such as type 1 diabetes, autoimmune thyroid disease, coeliac disease, or pernicious anaemia have a higher risk of developing autoimmune Addison’s disease, as the immune system may target multiple endocrine organs (Mayo Clinic, 2024; Cleveland Clinic, 2022). Addison’s disease may also occur as part of autoimmune polyendocrine syndromes, which further increase susceptibility (NHS, 2021).

A family history of Addison’s disease or autoimmune endocrine disorders is another recognised risk factor, suggesting a genetic predisposition. Certain inherited conditions affecting immune regulation can increase the likelihood of adrenal gland damage (Mayo Clinic, 2024).

Individuals with a history of infections affecting the adrenal glands, particularly tuberculosis, are at increased risk, especially in regions where such infections remain prevalent. Chronic fungal infections and HIV-related complications may also contribute to adrenal damage (NHS, 2021).

Previous adrenal surgery, adrenal haemorrhage, or cancer that has spread to the adrenal glands can raise the risk of developing Addison’s disease by directly impairing adrenal function (Cleveland Clinic, 2022). Additionally, long-term use of oral or injected corticosteroids, followed by abrupt withdrawal, may increase the risk of adrenal insufficiency, particularly if medical supervision is inadequate (National Institute of Diabetes and Digestive and Kidney Diseases, 2019).

Addison’s disease can affect people of any age, but it is most commonly diagnosed in adults between 30 and 50 years, with a slightly higher prevalence in women, likely reflecting patterns seen in autoimmune diseases more broadly (Mayo Clinic, 2024).

Complications

If Addison’s disease is not diagnosed or adequately treated, it can lead to serious and potentially life-threatening complications. These complications primarily arise from prolonged deficiencies of cortisol and aldosterone, which are essential for maintaining cardiovascular stability, electrolyte balance, and the body’s response to stress (NHS, 2021).

The most severe complication is an adrenal crisis (also known as an Addisonian crisis). This is a medical emergency characterised by sudden and profound worsening of symptoms, including severe weakness, confusion, vomiting, dehydration, very low blood pressure, and loss of consciousness. Adrenal crisis can be triggered by physical stress such as infection, surgery, trauma, severe dehydration, or abruptly stopping steroid medication without medical supervision (Cleveland Clinic, 2022; National Institute of Diabetes and Digestive and Kidney Diseases, 2019). Without prompt treatment, an adrenal crisis can be fatal (NHS, 2021).

Electrolyte imbalances, particularly low sodium (hyponatraemia) and high potassium (hyperkalaemia), are common complications due to aldosterone deficiency. These imbalances can cause muscle cramps, irregular heart rhythms, low blood pressure, and in severe cases, cardiac complications (Mayo Clinic, 2024).

Individuals with Addison’s disease may also experience recurrent episodes of low blood sugar (hypoglycaemia), especially during illness or fasting, as cortisol plays a key role in glucose regulation. This can lead to symptoms such as sweating, shakiness, confusion, and fainting (NHS, 2021).

When Addison’s disease is part of an autoimmune polyendocrine syndrome, additional complications may arise from co-existing autoimmune conditions, such as thyroid dysfunction, type 1 diabetes, or gastrointestinal disorders. Managing multiple conditions simultaneously can increase treatment complexity and healthcare burden (Cleveland Clinic, 2022).

Although these complications can be serious, early diagnosis, appropriate hormone replacement therapy, and patient education, including sick-day rules and emergency steroid use, significantly reduce the risk and allow most individuals to live stable, active lives (National Institute of Diabetes and Digestive and Kidney Diseases, 2019).

Prognosis

The prognosis for Addison’s disease is generally good when the condition is diagnosed early and managed appropriately. With lifelong hormone replacement therapy and regular medical follow-up, most individuals are able to lead normal, active lives with minimal long-term limitations (NHS, 2021; National Institute of Diabetes and Digestive and Kidney Diseases, 2019).

Effective treatment replaces the hormones that the adrenal glands are unable to produce, primarily cortisol and, where necessary, aldosterone. When medication is taken consistently and adjusted during periods of illness or stress, symptoms are usually well controlled, and quality of life is largely preserved (Mayo Clinic, 2024).

However, the prognosis can be seriously compromised if Addison’s disease remains undiagnosed or poorly managed. The main long-term risk is adrenal crisis, which can be life-threatening if not treated promptly. The risk of such emergencies is significantly reduced through patient education, adherence to prescribed treatment, and awareness of “sick day rules” (Cleveland Clinic, 2022; National Institute of Diabetes and Digestive and Kidney Diseases, 2019).

Individuals with co-existing autoimmune conditions may require more complex, ongoing medical care, but this does not necessarily worsen outcomes if conditions are appropriately monitored and treated (NHS, 2021). Advances in clinical awareness, diagnostic testing, and patient education have contributed to improved survival rates and long-term outcomes in recent decades (Mayo Clinic, 2024).

Nutritional perspective

Nutrition plays a supportive but important role in the management of Addison’s disease alongside medical treatment. While diet cannot replace hormone replacement therapy, appropriate nutritional choices can help manage symptoms, support energy levels, and reduce the risk of complications related to electrolyte imbalance and low blood pressure (NHS, 2021; Mayo Clinic, 2024).

Because aldosterone deficiency can lead to low sodium levels, some individuals with Addison’s disease may be advised to maintain an adequate salt intake, particularly during hot weather, exercise, illness, or periods of excessive sweating. This should always be guided by a healthcare professional to avoid overcorrection (NHS, 2021; National Institute of Diabetes and Digestive and Kidney Diseases, 2019).

Maintaining stable blood sugar levels is also important, as cortisol plays a role in glucose regulation. Regular meals containing complex carbohydrates, adequate protein, and healthy fats may help prevent fatigue, dizziness, and episodes of low blood sugar. Skipping meals or prolonged fasting may worsen symptoms in some individuals (Mayo Clinic, 2024).

A balanced diet rich in fruits, vegetables, whole grains, lean proteins, and calcium-rich foods supports overall health and bone strength, particularly as long-term steroid replacement therapy may increase the risk of reduced bone density (Cleveland Clinic, 2022). Adequate intake of calcium and vitamin D is therefore often encouraged as part of general health advice (NHS, 2021).

During periods of illness, stress, vomiting, or diarrhoea, nutritional intake may be compromised, increasing the risk of dehydration and adrenal crisis. In such situations, maintaining fluid intake, electrolytes, and following prescribed sick-day rules is essential, and medical advice should be sought promptly if oral intake is reduced (National Institute of Diabetes and Digestive and Kidney Diseases, 2019).

Psychological perspective

Addison’s disease can have a significant psychological and emotional impact, as cortisol plays an important role in mood regulation, stress response, and cognitive functioning. Both the physiological effects of hormone deficiency and the demands of long-term condition management can influence mental wellbeing (NHS, 2021; Mayo Clinic, 2024).

Individuals with Addison’s disease commonly report low mood, anxiety, irritability, and reduced stress tolerance, particularly before diagnosis or during periods of hormonal imbalance. Chronic fatigue and fluctuating energy levels may also affect motivation, concentration, and overall quality of life (Cleveland Clinic, 2022). These symptoms can sometimes be misattributed solely to psychological causes, potentially delaying diagnosis (NHS, 2021).

Living with a lifelong condition that requires daily medication, emergency planning, and ongoing medical monitoring can contribute to emotional strain. Fear of adrenal crisis, concerns about illness, and the need to adjust medication during stress or infection may lead to heightened health-related anxiety in some individuals (National Institute of Diabetes and Digestive and Kidney Diseases, 2019).

Social and occupational functioning may also be affected. Persistent fatigue or cognitive “fog” can interfere with work performance, relationships, and social engagement, which in turn may contribute to feelings of isolation or reduced self-esteem (Mayo Clinic, 2024).

Psychological well-being often improves when Addison’s disease is appropriately diagnosed and medically stabilised, and when individuals receive education, reassurance, and ongoing support. Access to psychological support, stress-management strategies, and clear medical guidance can help individuals adapt to living with the condition and maintain a good quality of life (NHS, 2021; National Institute of Diabetes and Digestive and Kidney Diseases, 2019).

Homeopathic perspective

From a homoeopathic perspective, Addison’s disease is viewed as a chronic constitutional condition affecting the body’s overall vitality and stress response. Homoeopathy does not replace conventional medical treatment for Addison’s disease, which requires lifelong hormone replacement therapy, but it may be used only as a complementary approach alongside standard care, under appropriate medical supervision.

Homoeopathic practice emphasises an individualised approach, considering the person’s physical symptoms, emotional state, stress patterns, energy levels, sleep, appetite, and response to environmental factors. Rather than targeting the adrenal glands in isolation, homoeopathy aims to support the individual as a whole, particularly in coping with fatigue, stress intolerance, low mood, and reduced resilience, which are commonly experienced in Addison’s disease.

People living with Addison’s disease may seek complementary approaches to help them adjust to chronic illness, manage stress, and improve perceived well-being. Stress management is particularly relevant, as physical or emotional stress can exacerbate symptoms and increase the risk of adrenal crisis if not medically managed.

It is essential to emphasise that homoeopathic remedies must never be used as a substitute for prescribed steroid medication, and any complementary therapy should be communicated clearly to the individual’s healthcare team. Abrupt changes to medical treatment can be dangerous and may lead to serious complications.

When used responsibly and in conjunction with conventional care, a complementary homoeopathic approach may focus on supporting overall well-being, stress adaptation, and quality of life, while recognising the central role of evidence-based medical management in ensuring safety and long-term prognosis.

Summary

Addison’s disease is a rare but serious long-term endocrine condition caused by inadequate production of cortisol and, in many cases, aldosterone due to damage to the adrenal glands. Because these hormones are essential for regulating metabolism, blood pressure, immune function, and the body’s response to stress, untreated Addison’s disease can lead to significant health risks.

Symptoms often develop gradually and may include persistent fatigue, weight loss, low blood pressure, skin hyperpigmentation, salt cravings, and psychological changes, which can delay diagnosis. If not appropriately managed, the condition can result in adrenal crisis, a potentially life-threatening medical emergency.

With early diagnosis, lifelong hormone replacement therapy, and patient education, the prognosis for Addison’s disease is generally good, allowing most individuals to lead stable and active lives. Supportive approaches, including appropriate nutrition, psychological support, and carefully managed complementary therapies, may help improve overall wellbeing when used alongside conventional medical treatment.

Ongoing medical follow-up, adherence to prescribed treatment, and awareness of stress-related risks remain central to the safe and effective management of Addison’s disease.

---

CMA Continuing Professional Development (CPD) Reflective Practice

CMA CPD Value: 1 Hour CPD

Addison’s disease is a complex endocrine disorder with wide-ranging physical, psychological, and functional implications. As complementary medicine, integrative medicine and holistic therapy professionals, it is essential that we understand the condition, recognise its potential impact on clients, and practise safely, ethically, and within our professional scope.

Please reflect carefully on the following questions and record your responses within your CMA CPD journal. We suggest you either print, scan (or photograph) and then upload to your CMA CPD log, which you can find by logging in your CMA Membership section. Do check out other CMA/CPD earning opportunities here.

Clinical Awareness and Recognition

• Before reading this article, how familiar were you with Addison’s disease and its underlying hormonal mechanisms?
• What key signs and symptoms might alert you that a client could be living with adrenal insufficiency, diagnosed or undiagnosed?
• How might the non-specific nature of symptoms such as fatigue, dizziness, and low mood affect your client assessment process?

Professional Scope, Safety and Responsibility

• Why is it essential that Addison’s disease is medically diagnosed and managed with hormone replacement therapy?
• How would you ensure that your professional communication never implies that complementary approaches could replace essential medical treatment?
• Are you confident in recognising when referral to a GP or appropriate medical professional may be necessary to protect client safety?

Holistic and Integrative Support

• How might Addison’s disease affect a client’s physical energy, emotional wellbeing, stress tolerance, and quality of life?
• Within your professional scope, how could you support a client’s overall wellbeing while respecting the central importance of their medical treatment plan?
• How does this article reinforce the importance of working collaboratively within an integrative healthcare framework?

Professional Growth and Practice Integration

• What new understanding have you gained about the relationship between endocrine health, stress physiology, and whole-person wellbeing?
• How will this knowledge influence your future client consultations, case history taking, or professional decision-making?
• What further study or education might strengthen your competence in supporting clients with complex medical conditions?

Your CPD Action Commitment

Please complete the statement below:

“As a result of this learning, one specific action I will take to strengthen my professional awareness and improve client safety is:”

Reflection Summary

In your CPD journal, write a brief reflective summary (approximately 150–300 words) outlining:

• Your key learning points from this article
• Why this knowledge is relevant to your professional role
• How this learning will help you practise more safely, confidently, and effectively

CPD Recording Instructions

Please record the following in your CMA CPD log:

• Date of completion
• Article title: Addison’s Disease: Clinical and Holistic Perspectives
• Learning activity: Reading and reflective practice
• CPD hours claimed: 1 Hour
• Summary of learning and reflection

This reflective process supports your ongoing development as a safe, ethical and competent complementary, integrative or holistic health professional.

---

References

Cleveland Clinic. (2022, July 6). Addison’s disease. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/15095-addisons-disease

Mayo Clinic . (2024, December 21). Addison’s Disease – Symptoms and Causes. Mayo Clinic; Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/addisons-disease/symptoms-causes/syc-20350293

NHS. (2021). Overview – Addison’s disease. NHS. https://www.nhs.uk/conditions/addisons-disease/

National Institute of Diabetes and Digestive and Kidney Diseases. (2019, March 22). Adrenal Insufficiency & Addison’s Disease. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/endocrine-diseases/adrenal-insufficiency-addisons-disease

About the Author

Amrita Singh is a qualified Homoeopath, Psychologist, and Nutritionist with a strong multidisciplinary foundation in mind–body health. She holds an MSc in Psychology (UK) and an MSc in Food, Nutrition & Dietetics (India), alongside formal training in classical homoeopathy from the Central College of Homoeopathy, London. She is currently pursuing postgraduate studies with the Irish School of Homoeopathy.

A full member of the Complementary Medical Association (MCMA), Homoeopathy International (R. Hom. Int.), the British Psychological Society (Graduate Member), and Balen’s insured, Amrita integrates emotional insight, nutritional balance, and gentle homoeopathic care in her clinical approach.

Formerly the Head of Department at RMCH&RC, she now works with clients internationally & runs two physical clinics (Meerut City, Uttar Pradesh & Ambala Cantt., Haryana) in India, offering compassionate, holistic guidance that honours the interconnectedness of emotional wellbeing, physical health, and lifestyle patterns.

Contact & Credentials

Amrita Singh
Homoeopath, Psychologist & Nutritionist
Dip. CCH (England) | MSc Psychology (England) | MSc Food, Nutrition & Dietetics (India)
MCMA | R. Hom. Int. (Balen’s Insured) | GMBPsS

📧 [email protected]
🌐 https://amritasingh.co.uk/
📍 United Kingdom

Instagram – https://www.instagram.com/clinic_uk_2025/

Facebook – https://www.facebook.com/profile.php?id=61582871564526